The FDA has received many hundreds of adverse event reports involving IVC filters, involving device migration, embolization (detachment of device components), perforation of the inferior vena cava and internal organs, and filter fracture. These events have caused numerous serious injuries and death. The FDA has published two safety notices, which warn of the large number of adverse events and that despite having been cleared for permanent implantation, these devices should be removed as soon as the risk of pulmonary embolism has passed.
Formed in 2015, the IVC Filters Litigation Group promotes and facilitates cooperation and sharing of information and ideas among its members with regard to prosecution and handling of claims on behalf of consumers injured by defective IVC Filters. The Group hosts meetings at the AAJ Annual and Winter Conventions and provides tools and resources for members to successfully litigate their cases. Group members network and discuss legal issues and strategies on the Group's plaintiff-only list server and at regular meetings, including AAJ Conventions and Education seminars.
The IVC Filter Litigation Group is sponsored by CAMG.